Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Enterprise Mobility Leader Globo Begins Trading on the OTCQX International Exchange in the U.S.
-
Intersect ENT (XENT) Commences 3M Common Stock Offering
-
Intersect ENT Commences Public Offering
-
Immunogen (IMGN) PT Lifted to $20 at Canaccord Genuity Following IMGN853 ASCO Data
-
Hologic (HOLX) PT Boosted to $40 at Canaccord Genuity Following Meetings
-
Canaccord Genuity Raised Price Target Following Investor Meetings with Skyworks Solutions (SWKS)
-
Canaccord Genuity Raises Price Target on ePlus (PLUS) Following Q4 Results
-
North American Financial 15 Split Corp. Announces Successful Overnight Offering
-
Avago (AVGO) PT Raised to $170 at Canaccord Genuity Amid Broadcom (BRCM) Deal
-
Orsu Metals Corporation: Notice of Annual Shareholder Meeting and Posting of Circular
-
North American Financial 15 Split Corp. Announces Overnight Offering
-
Notable Analyst Rating Changes 5/28: (RL) (JCI) (GM) Upgraded; (BT) (BONT) (TFM) Downgraded
-
Canaccord Genuity Strengthens Global Healthcare and Technology Capability with Addition of Key Investment Banking and Research Professionals
-
Canaccord Genuity Reiterates Buy Ahead of Deckers Outdoor (DECK) Q4 Results
-
Canaccord Genuity Cuts Price Target on Michael Kors (KORS) Following Q4
-
Canaccord Genuity Raised Price Target on SolarEdge Technologies (SEDG) Following Investor Meetings
-
Dividend 15 Split Corp. Completes Overnight Offering of $94,170,000
-
Canaccord Genuity Downgrades Magnum Hunter (MHR) to Hold
-
Seres Therapeutics (MCRB) Files for $100M IPO
-
Shopify Announces Closing of Initial Public Offering and Exercise of Underwriters' Over-Allotment Option
-
Shopify Announces Closing of Initial Public Offering and Exercise of Underwriters' Over-Allotment Option
-
Canaccord Genuity Reiterate Buy Following Workday (WDAY) Q1
-
Notable 52-Week Highs and Lows 5/26: (CVC) (DE) (PANW) High; (ACI) (ANR) (KORS) Low
-
Canaccord Genuity Raised Price Target on Foot Locker (FL) Following Q1 Results
-
Canaccord Genuity Cuts Price Target to $63 on Michael Kors (KORS) Following Industry Checks
-
AirXpanders Announces Initial Public Offering in Australia
-
ProMetic Announces the Exercise of the Over-Allotment Option Under Its Bought Deal Offering of Common Shares
-
Revolutionary US Medical Device Company AirXpanders to List on ASX
-
Aldeyra Therapeutics Announces Closing of Common Stock Offering
-
Unusual 11 Mid-Day Movers 5/22: (ABTL) (ONTY) (RWLK) Higher; (OTIC) (CNIT) (VGGL) Lower
-
Notable Analyst Rating Changes 5/22: (RWLK) (BAH) (DOV) Upgraded; (GD) (JGW) (CONN) Downgraded
-
UPDATE: Canaccord Genuity Upgrades ReWalk Robotics Ltd. (RWLK) to Buy
-
UPDATE: Canaccord Genuity Starts Synergy Pharmaceuticals (SGYP) at Buy, PT $11
-
Tungsten Corporation Plc: Completion of Placings
-
Canaccord Genuity Raised Price Target on salesforce.com (CRM) Following Q1 Results
-
Canaccord Genuity Remains Bullish on Spectranetics (SPNC) Following an Update on Stellarex DCB
-
Canaccord Genuity Raised the Price Target to $85 on SAGE Therapeutics (SAGE) as they Prepare to Enter Phase 3 STATUS Trial
-
Canaccord Genuity Remains Bullish Ahead of DSW's (DSW) Q1 Results
-
Shopify (SHOP) IPO Opens Up 65%
-
Intersect ENT Files S-1 Registration Statement for Proposed Public Offering
-
Shopify Inc. (SHOP) Prices 7.7M Common IPO at $17/Share, Above Previously Expected Range
-
Shopify Announces Pricing of Initial Public Offering
-
Veresen Announces Common Share Dividend for May 2015 and Quarterly Dividend on Its Preferred Shares
-
Canaccord Genuity Maintains Buy Following Erickson (EAC) Meetings
-
Canaccord Genuity Remains Bullish Following Globus Medical (GMED) Marketing Meetings
-
UPDATE: Canaccord Genuity Upgrades Sarepta Therapeutic (SRPT) to Buy
-
Cepheid (CPHD) Investor Meetings Build Confidence, Canaccord Genuity Says; PT to $68
-
Regeneron Pharma (REGN) PT Raised to $600 at Canaccord Genuity
-
Canaccord Genuity Reiterates Buy Following Calamp Corp. (CAMP) Investor Meetings
-
CohBar Announces Commencement of Trading on the OTCQX Marketplace


